Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 235

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 235
---
oom access to Tribe Capital Growth after executing a non-disclosure agreement on June 1, 2021. Tribe Capital Growth conducted a deep dive analysis and due diligence showed that Target D was far ahead of its competition and with generic social discovery on the rise, Target D was well-positioned to capture this value, particularly among the Gen-Z users.

Once discussions with Target C were shelved, Tribe Capital Growth re-initiated negotiations with Target D and commenced preparing a letter of intent in March 2022. In April 2022, Tribe Capital Growth submitted a non-binding letter of intent but did not proceed as Target D was not very responsive.

### Change in Sponsorship and SPAC Management
On June 1, 2022, Tribe Capital withdrew as a member of Tribe Capital Growth’s sponsor, Tribe Arrow Holdings I LLC, a Delaware limited liability company (“Tribe Arrow Holdings”). Subsequently, Arrow Multi Asset Fund — Arrow SP6 was admitted as a member of Tribe Arrow Holdings and appointed as the sole managing member of Tribe Arrow Holdings. The CEO, CFO and Secretary of Tribe Capital Growth, who were a part of the Tribe Capital team, resigned, along with an independent director. Following the transition, Tribe Capital Growth was renamed to Iris Acquisition Corp and changed its strategy to adopt a sector-agnostic approach with respect to deal sourcing, underwriting and selection criteria of potential business combination targets. Tribe Arrow Holdings was renamed Iris Acquisition Holdings LLC. Our Sponsor is

<div align='center'>109</div>

TABLE OF CONTENTS

owned by: (i) a private equity fund managed by Arrow and (ii) Iris Equity Holdings LLC. Iris Equity Holdings LLC is the managing member of our Sponsor.

Negotiations with potential target companies as Iris Acquisition Corp*

Post transition to Iris Acquisition Corp, Iris explored several other targets that fit its revised strategy. While several discussions to understand their respective businesses and potential deal terms took place between Iris and the management of these companies, none of them were provided a letter of intent by Iris. The companies included the following:

•

A digital logistics company with strong 10-year track record that operated in the ASEAN and African markets. The company had built strong partnerships across the world servicing over 650 customers, most of whom were globally recognized names.

•

A UK-based app management company that focused on mobile advertising and digital cybersecurity. However, the company required immediate cash and given the de-SPAC timeline, Iris and the company mutually agreed to end discussions.

•

A South Asian fintech enabler that focused on